Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-042462
Filing Date
2013-08-02
Accepted
2013-08-02 13:58:17
Documents
1
Period of Report
2013-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd387205.html 3  
1 FORM 3 rrd387205.xml 3 10417
  Complete submission text file 0001181431-13-042462.txt   11826
Mailing Address 837 4TH AVE SALT LAKE CITY UT 84103
Business Address
SIMMONS GERALD T (Reporting) CIK: 0001007878 (see all company filings)

Type: 3 | Act: 34 | File No.: 333-178230 | Film No.: 131005848

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations